5-HT2C Receptor Agonists for the Treatment of Obesity. Biological and Chemical Adventures

5-HT2C Receptor Agonists for the Treatment of Obesity. Biological and Chemical Adventures

Obesity is a major risk factor in the development of conditions such as hypertension, hyperglycemia, dyslipidemia, coronary artery disease and cancer. There is increasing evidence suggesting an important role for the 5-HT2C receptor in appetite control. Collaboration between F. Hoffmann-La...

Full description

Bibliographic Details
Main Authors: David Adams, Sven Taylor, Stephan Röver, Hans Richter, Jean-Marc Plancher, Jacques Mizrahi, Craig S. Malcolm, Antony R. Knight, Guy A. Kennett, Paul Hebeisen, Ian A. Cliffe, Anne Bourson, Caterina Bissantz, Jon M. Bentley, Mike J. Bickerdike, Agnès Bénardeau, Steven P. Vickers
Format: Article
Language:deu
Published: Swiss Chemical Society 2004-09-01
Series:CHIMIA
Subjects:
Obesity
Pyrroloindole
5-ht2c receptor agonist
Sulfamidate
Online Access:https://chimia.ch/chimia/article/view/3877

Internet

https://chimia.ch/chimia/article/view/3877

Similar Items